We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Finally Releases Guidance on Breakthrough Therapy Designation
FDA Finally Releases Guidance on Breakthrough Therapy Designation
July 17, 2013
The FDA has issued a long-awaited guidance outlining how pharma companies can receive a breakthrough therapy designation for a new drug, opening a door to faster approval.